ArticleBreast cancer (Tokyo, Japan)2025

The impact of axillary lymph-node dissection omission on adjuvant abemaciclib eligibility in HR-positive, HER2-negative breast cancer with positive sentinel lymph nodes.

Kei Kawashima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.